Abstract. Increased numbers of corpora amylacea have been observed in the resected mesial temporal lobe of many patients with complex partial seizures (CPS) and Ammon's horn sclerosis (AHS). Several heat shock proteins (HSPs) are induced by seizures and have been suggested as an etiologic factor in the formation corpora amylacea. We quantified corpora amylacea and HSP27-immunoreactive astrocytes in temporal lobe specimens from patients with CPS (28 AHS; 10 non-AHS) and in 5 autopsy controls. Corpora amylacea were increased in each sector of Ammon's horn in the AHS group, significantly so in CA 1 and CA 3 (p Ͻ 0.0001 and p ϭ 0.0097, respectively), compared with the non-AHS group, although there was considerable variability among the specimens. We found HSP27 to be significantly but nonspecifically increased in the resected temporal lobe specimens from all patients with CPS, regardless of the underlying pathology. HSP27 was not, however, expressed within the corpora amylacea, and did not correlate with the number of corpora amylacea in any of the 9 mesial and lateral temporal lobe areas examined.
INTRODUCTION
Increased numbers of corpora amylacea have been described in hippocampal tissue from patients with temporal lobe epilepsy and Ammon's horn sclerosis (AHS) (1) (2) (3) (4) . Although corpora amylacea or similar bodies are found in other organs, corpora amylacea have been most thoroughly studied in the brain. The number of corpora amylacea in the brain normally increases with age, and is also increased in a number of neurologic diseases, including motor neuron disease, multiple sclerosis, Alzheimer disease, and Lennox-Gastaut syndrome (5) (6) (7) (8) (9) . Although the function of corpora amylacea is not well understood, most evidence suggests that they are involved in the sequestration of potentially hazardous products of cellular metabolism (5) . When present in large numbers, corpora amylacea are pathognomonic of several diseases, including adult polyglucosan body disease and the Lafora body form of myoclonic epilepsy. The Lafora bodies have a slightly different staining pattern because of variations in the esterification of the glucose polymer (10) .
In aged brains, corpora amylacea are characteristically distributed along the margin of blood vessels, beneath the pial border of the hippocampus, and in the subependymal zones of the ventricles. In persons without known neurologic disease, corpora amylacea are found in the processes of fibrillary astrocytes and in neuronal axons. They are also found in the perikarya of neurons in several neurologic diseases, most notably in Lafora body disease (5) .
Evidence exists to suggest that corpora amylacea may originate in oligodendrocytes and neurons as well as astrocytes, but their genesis is poorly understood (5, 11) .
In the mid-1800s, Virchow described the appearance of these bodies in the central nervous system, strongly believing them to be composed of vegetable starch (12) . Numerous biochemical descriptions of these bodies accumulated in the ensuing years (13) (14) (15) , but it wasn't until 1969 that Sakai and associates described corpora amylacea as mainly composed of polyglucosans (16) . Corpora amylacea are now considered to consist of approximately 80% glycogen, 1% phosphate, 0.7% sulfate, 5% protein (16) (17) (18) , and small amounts of iron, calcium, and copper (19) . They have a common antigenicity to the Lafora body and to the intracytoplasmic inclusions observed in type IV glycogenosis (20) .
The protein content of corpora amylacea in the brain has been analyzed using immunochemical techniques by Cisse and co-workers (8, 18) . They have demonstrated that corpora amylacea react positively with antibodies to ubiquitin and several heat shock proteins, and suggest that the accumulation of these proteins may reflect sustained physiological stress (8, 21) . Heat shock proteins are produced by cells in response to (1) environmental stress, particularly heat, anoxia, ethanol, and heavy metals; (2) pathophysiological states such as inflammation and ischemia; and (3) conditions involving cell growth and development. Plumier and associates recently demonstrated that kainic acid-induced status epilepticus in a rat model increased the expression of HSP27 significantly (22) . This small HSP appeared in reactive astrocytes approximately 12 h after treatment, following the appearance of HSP70, which appeared approximately 6 h after treatment. HSP27 has also been found to be increased in patients with Alzheimer disease (23) , and in patients with malignant brain tumors (24, 25) . In patients with brain tumors, HSP27 immunoreactivity is proportional to the degree of anaplasia, and has been linked with drug resistance (24) . Because several HSPs have been identified in human corpora amylacea (8, 26) , which in turn are increased in many patients with complex partial seizures (CPS) and AHS (1-4), and because HSP27 has been shown to be increased following experimentally induced seizures (22), we examined the relationship between HSP27 and corpora amylacea in resected mesial and lateral temporal lobe tissue from patients with CPS and AHS or other pathology. We also examined the relationship between the number of corpora amylacea and seizure history and, in AHS specimens, between corpora amylacea and neuronal loss.
MATERIALS AND METHODS

Specimens
Specimens from 38 patients with intractable CPS (Table 1) who underwent anterior temporal lobectomy (ATL) at The Methodist Hospital, Baylor College of Medicine Epilepsy Center were examined. Five autopsy specimens from patients with no known neurologic disease were also examined.
Resection of the hippocampus and adjacent lateral temporal lobe resulted in 2 specimens, 1 of the mesial and 1 of the lateral temporal lobe. Serial blocks were cut from each specimen, and alternate blocks were fixed in 10% buffered formalin or 4% paraformaldehyde. For traditional neuropathologic examination of the tissue, 5-m sections from comparable portions of the formalin-fixed tissue were stained with hematoxylin and eosin (H&E) and cresyl violet. For quantification of corporal amylacea, comparable 5-m sections from the mesial and lateral temporal lobes of each patient were stained with PAS.
The paraformaldehyde-fixed sections were placed in sucrose, frozen, cut at 50 m and examined with immunocytochemical techniques for tyrosine hydroxylase, parvalbumin, HSP27 (dilution 1:250; BioGenex, San Ramon, CA), HSP70-72 (dilution 1:250; StressGen Biotechnologies Corp., Victoria, B.C.), and HSP90 (dilution 1:500; StressGen Biotechnologies Corp., Victoria, B.C.). Our previous work has shown that the patterns of immunoreactivity to tyrosine hydroxylase (27) and parvalbumin (28) are useful in diagnosing classical AHS. The HSP27 antibody used was a mouse-derived monoclonal antibody, which previous studies have shown to react strongly in human brain tissue. Immunoreactivity to HSPs 70-72 and 90 was examined in randomly selected specimens (N ϭ 3 for each) for comparison with other published studies.
Specimens defined histologically as classical AHS demonstrated the following characteristics: (1) the loss of pyramidal neurons in CA 1 and CA 4 of Ammon's horn; (2) the loss of granule cell neurons in the dentate gyrus; (3) the presence of tyrosine hydroxylase-immunoreactive neurons in CA 4 ; (4) decreased numbers of parvalbumin-immunoreactive neurons in CA 4 ; and (5) varying degrees of gliosis (27) (28) (29) (30) . The degree of neuronal loss in each hippocampal sector of the AHS specimens was graded based on the greatest loss observed. A normal appearance, with no apparent loss of neurons, was graded as 0; minimal loss of neurons was graded as 1; moderate neuronal loss was graded as 2; an occasional remaining neuron was graded as 3; and complete loss of neurons was graded as 4. Specimens from CPS patients with pathology other than AHS were, for the purposes of this study, grouped together as non-AHS.
Quantification
For enumeration of corpora amylacea, examination was restricted to 2 comparable PAS-stained sections from each of the 38 CPS and 5 control specimens: 1 from the mesial temporal lobe that included the hippocampus and 1 from the lateral temporal lobe. In each section examined, PAS-positive bodies 1 m or more in diameter that were clearly visible were counted as corpora amylacea. The enumeration was done manually with a hand counter and examination of 1 to 10 microscopic fields, using a 4ϫ objective. Some of the areas examined, e.g., CA 4 , CA 3 and CA 2 , could be examined in their entirety in several fields. For CA 1 , the subiculum, the parahippocampal cortex and white matter cortex, and the lateral temporal cortex and white matter, 10 different microscopic fields were examined, focusing on those areas with the greatest number of corpora amylacea. For each patient, the mean number of corpora amylacea in each area examined was used for subsequent analyses. For HSP27 immunoreactivity, examination was restricted to 4 sections: 2 adjacent sections from the hippocampus that included Ammon's horn, and 2 adjacent sections from the lateral temporal lobe. Of the 38 CPS specimens analyzed for corpora amylacea, 33 specimens were examined for the presence of HSP27 immunoreactivity. In 7 of the 33 specimens, no lateral temporal lobe tissue was available for HSP27 analysis, and in 9 instances no CA 3 or CA 2 tissue was available for HSP27 analysis. All 5 autopsy controls were analyzed for HSP27. The numbers of HSP27-positive astrocytes were enumerated manually for each sector of Ammon's horn, the subiculum, the parahippocampal white matter, and the lateral temporal lobe cortex and white matter.
Patient characteristics and measures of seizure history, including average number of CPSs per week, age of CPS onset, and duration of CPS, were obtained from patient histories and previously completed patient questionnaires.
Statistics
The mean and standard deviation were used to describe patient characteristics, and the number of corpora amylacea and HSP27-positive astrocytes in each of the areas examined. Because the number of corpora amylacea by patient was not normally distributed, the median and ranges were also used to describe these data. The Wilcoxon rank-sum test for nonparametric data was used to analyze the number of corpora amylacea by pathologic diagnosis (AHS vs non-AHS), and by neuronal loss in the AHS specimens. To examine the relationships between the corpora amylacea and continuous variables, including the number of HSP27-immunoreactive astrocytes in each sector and various measures of seizure history, Spearman's rank-order correlation method was used. One-way analysis of variance was used to analyze the number of HSP27-immunoreactive astrocytes in each sector by pathologic diagnosis. JMP statistical software, version 3.1 (SAS Institute Inc., Cary, NC) was used for the analyses. Alpha was set at 0.05.
RESULTS
The patients' ages at surgery ranged from 9.0 to 56.9 yr (mean 30.5 Ϯ SD 11.0), and the durations of their seizure disorder ranged from 3.5 to 41.9 yr (mean 19.1 Ϯ SD 9.6) ( Table 1 ). There were 15 males and 23 females. The side of seizure onset and surgery was on the right in 23 patients, and on the left in 15 patients. Pathologic examination revealed 28 specimens with AHS (27 with classical AHS and 1 with atypical AHS), and 10 non-AHS specimens with the diagnosis of either ganglioglioma (GG, N ϭ 6), microdysgenesis (MD, N ϭ 1), GG and MD (N ϭ 1), or dysembryoplastic neuroepithelial tumor (DNET, N ϭ 2).
Staining with PAS revealed many more corporal amylacea than were apparent with H&E staining. The corpora amylacea ranged in size from 1 m to 15 m in diameter.
They were intensely PAS-positive. Some of the larger bodies had an irregular staining pattern. The corpora amylacea were most concentrated under the pia (Fig. 1) , and around blood vessels. In the AHS specimens, they were also scattered within the layers of Ammon's horn, with no apparent relationship to any cell type. The mean and median numbers of corpora amylacea in 9 areas of the mesial and lateral temporal lobe are shown in Table  2 . When the number of corpora amylacea in each sector in specimens with AHS were compared with the number of corpora amylacea in specimens with non-AHS pathology, significantly more corpora amylacea were observed in CA 1 and in CA 3 in the AHS specimens (p Ͻ 0.0001 and p ϭ 0.0097, respectively; Table 2 ). The number of corpora amylacea were also noticeably increased in CA 4 and CA 2 in the AHS patients, and in the parahippocampal white matter in the non-AHS patients, but these differences were not statistically significant. Although the number of corpora amylacea in Ammon's horn were markedly elevated in the majority of AHS specimens, there was considerable variability among the specimens. For example, in CA 1 in which the mean number of corpora amylacea was elevated by a factor of approximately 15 (18.69 in AHS vs 1.20 in non-AHS, p Ͻ 0.0001), 6 of the 28 AHS specimens nevertheless had 3 or fewer corpora amylacea in this sector.
The relationship between seizure history in the 38 CPS patients and the number of corpora amylacea in each of the 9 regions examined was also examined. Statistically significant correlations were observed between the number of corpora amylacea in CA 2 , CA 3 and the subiculum and the duration of CPS (p ϭ 0.0122, p ϭ 0.0150, and p ϭ 0.0365, respectively) in patients with AHS. Statistically significant correlations were also observed between the number of corpora amylacea in CA 1 and a computed lifetime total of CPS (calculated as CPS per week ϫ 52 wk ϫ years of CPS) in patients with AHS (p ϭ 0.0275). Among the non-AHS patients, no statistically significant correlation was noted between the number of corpora amylacea in any sector and any measure of seizure history. The relationship between the number of corpora amylacea and neuronal loss in patients with AHS was also examined in each sector of Ammon's horn but no statistically significant relationship was noted (for example, p ϭ 0.2629 in CA 4 ; p ϭ 0.4236 in CA 1 ).
The temporal lobectomy specimens from all 38 patients with CPS revealed a considerable degree of immunoreactivity for HSP27 ( Fig. 2; Table 3 ). The staining patterns conformed to the shape of the astroglial cells. In The Wilcoxon rank-sum test for nonparametric data was used to compare the AHS and non-AHS groups. Abbreviations: AHS ϭ Ammon's horn sclerosis (see text); CA 4 -CA 1 ϭ sectors of Ammon's horn; ENTO ϭ entorhinal cortex; HWM ϭ hippocampal white matter; LTC ϭ lateral temporal cortex; LTWM ϭ lateral temporal white matter; non-AHS ϭ pathologic findings other than AHS (see text); SUB ϭ subiculum; * ϭ significant at p Ͻ 0.01; ** ϭ significant at p Ͻ 0.001. the hippocampus, they were located in the molecular layer, the pyramidal cell layer, the polymorphic cell layer, and the alveus. Not all of the astrocytes were decorated with the HSP27 antibody. In sectors where there was marked neuronal loss, as in CA 1 in AHS specimens, the HSP27-immunoreactive astrocytes often appeared small with fewer or shorter processes. There was no obvious selectivity to the sites of HSP27 reactivity in the hippocampus or in the lateral temporal lobe cortex or white matter. The corpora amylacea did not stain with anti-HSP27, although they were sometimes outlined by HSP27.
The mean number of HSP27-positive cells in each sector examined in the CPS patients is depicted in Table 3 ; no HSP27-immunoreactive astrocytes were observed in the control specimens. No significant difference between the number of HSP27-positive astrocytes in the AHS and in the non-AHS groups in any sector was noted.
No significant correlation was found between the numbers of HSP27-immunoreactive astrocytes and corpora amylacea in any of the 9 areas examined. A correlation was noted between the number of HSP27-positive astrocytes in the lateral temporal cortex and the number of corpora amylacea in the parahippocampal white matter and in the lateral temporal lobe white matter (p ϭ 0.0158 and p ϭ 0.0078, respectively) in the CPS specimens. These findings were irrespective of underlying pathology. In the AHS specimens, no significant correlation was observed between the numbers of HSP27-positive cells and neuronal loss in any of the 4 subfields of Ammon's horn (for example, the correlation between neuronal loss and HSP27 in CA 1 was F ϭ 0.5936 [p ϭ 0.6273]).
Analysis of ATL specimens with the antibodies for HSP70-72 and HSP90 demonstrated diffuse HSP70-72 immunoreactivity generally restricted to the neurons, and diffuse HSP90 immunoreactivity in both the neurons and astrocytes. Corpora amylacea were occasionally outlined by HSP70-72 and HSP90, but there was no definite staining within the corpora amylacea.
DISCUSSION
Chung and Horoupian used a semiquantitative scale to evaluate the number of corpora amylacea and neuronal loss in temporal lobe specimens, and noted that the number of corpora amylacea was significantly increased in 58% of their specimens with mesial temporal sclerosis, compared with autopsy specimens (3) . Van Paesschen and associates demonstrated that 63% of their hippocampal sclerosis specimens contained corpora amylacea, and that the highest densities were found in CA 1 (4). In our study, which focused on a comparison of 2 groups of patients with CPS (AHS and non-AHS), we found considerable differences in the number of corpora amylacea in some of the 9 areas examined but not in others. Even within CA 1 , the sector in which the AHS and non-AHS groups differed most significantly (p Ͻ 0.0001), not all AHS specimens had increased numbers of corpora amylacea. In this sector, 22 of the 28 AHS specimens (78.6%) had a mean number of corpora amylacea greater than that observed in any of the non-AHS specimens. Conversely, 6 of the AHS specimens had corpora amylacea counts in CA 1 (mean 1.72) virtually indistinguishable from those in CA 1 of the 10 non-AHS 10 specimens (mean 1.20). These findings suggest that different etiologic subgroups may exist in AHS patients. We would therefore urge caution in using corpora amylacea as a marker for mesial temporal sclerosis, as has been suggested by at least 1 study (3) , in the absence of other evidence.
Although we did not observe a correlation between neuronal loss and the number of corpora amylacea as did and Chung and Horoupian and Van Paesschen and associates (3, 4) , the significantly increased number of corpora amylacea observed in CA 1 , the hippocampal sector that characteristically shows the greatest neuronal loss in AHS, raises interesting questions about the relationship of corpora amylacea to the stresses of epilepsy.
Seizures may contribute to the formation of corpora amylacea because of the increased demands on the glucose metabolic pathways and the subsequent formation of stable ubiquitin conjugates with polyglucosan, which is augmented by the induction of various HSPs. In aging and disease, and after heat shock per se, the amount of stable ubiquitin conjugates increases, possibly because of an overloading of the ubiquitin-dependent proteolysis system with increased amounts of stress-induced heat shock proteins. Corpora amylacea contain, in addition to ubiquitin and heat shock protein, glucose polymers that immunostain with antibodies directed against mitochondrial epitopes (31) . Thus Cisse and associates have suggested that the biosynthesis of corpora amylacea may be related to oxidative stress-induced alterations in the mitochondrial enzymatic proteins involved in the metabolic pathway of glucose (18, 21, 31) . Our observations support the idea that seizures associated with CPS increase the expression of 1 of the small heat shock proteins, HSP27, in astrocytes. There is also an accumulation of corpora amylacea in CPS specimens, supporting the idea that the ubiquitin protease system is overloaded in a nonspecific way throughout the tissue.
Although HSP27 was significantly elevated in the astrocytes of our seizure patients, HSP27 was not identified within the corpora amylacea by our tissue immunocytochemical investigations. Cisse HSP28 and HSP70 immunoreactivity in corpora amylacea (8) , and Martin and associates have reported that antibodies to HSP72 decorated corpora amylacea but that the staining varied considerably (26) . Martin and associates found that the smallest corpora amylacea were strongly stained throughout, whereas the larger laminated bodies stained only at the periphery. We found no definite staining of corpora amylacea with HSP70-72. Whether the differences between our findings and those of others reflect variations in the underlying pathology, the antibodies used, the HSPs themselves, or some other factor is unclear. Plumier and associates, in discussing variations in staining with HSP27 observed in different rat models of epilepsy (32) , have postulated that monoclonal antibodies raised against human HSP27 may not be able to detect rat HSP27, and have noted that HSP27 exists in at least 2 isoforms (32). These observations may explain some of the conflicting findings in immunostaining for different HSPs reported in the literature.
The specific and statistically significant accumulation of corpora amylacea in CA 1 and CA 3 in AHS, compared with other pathologies, possibly reflects increased or focused physiologic stress in these 2 sectors of the hippocampus in AHS. The increased firing of neurons in these sectors may contribute to the burden on the glucose metabolic pathways, to neuronal degeneration, and to the formation of corpora amylacea. Singhrao and associates, Cavanagh, and others have suggested that corpora amylacea could be an indicator of neurodegeneration (5, 8, 19, 33) . Because of the association between febrile seizures and AHS in many but not all patients with AHS (34), it is also tempting to speculate upon the initial role of elevated temperature and upregulation of HSPs in the subsequent increase in numbers of corpora amylacea in the hippocampus in AHS. As our understanding of the roles of HSPs and corpora amylacea increases, it can be hoped that their presence in AHS may provide some clues to the cause and pathogenesis of AHS.
